“…In past decades, dihydropyrimidinones (DHPMs) and their derivatives have attracted considerable interest due to their heterocyclic scaffold and interesting pharmacological properties such as antiviral, antitumor, anti inflammatory as well their applications as calcium channel blockers and anticancer drugs (Ali et al, 2016;Desai et al, 2016;Xue et al, 2016;Dalil et al, 2016;Dhumaskar et al, 2014;Jetti et al, 2014). Different strategies have been used for the modification of 3,4-dihydropyrimidine-2(1H)-ones.…”